4.5 Interaction with other medicinal products and other forms of interaction  
 No formal interaction studies have been performed.  
 For the adjunctive use of verteporfin photodynamic therapy (PDT) and Lucentis in wet AMD and PM, see section  5.1. 
 For the adjunctive use of laser photocoagulation and Lucentis in DME and BRVO, see sections  4.2 and 5.1.  
 In clinical studies for the treatment of visual impairment due to DME, the outcome with regard to visual acuity or central retinal subfield thickness (CSFT ) in patients treated with Lucentis was not affected by concomitant treatment with thiazolidinediones.  
 Paediatric population  
 No interaction studies have been performed.  7  
